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 1 
Abstract 
Protein isoaspartyl methyltransferase (PIMT), an ancient enzyme with putative homologs 
in virtually all eukaryotes studied to date, is a protein repair enzyme that initiates restoration of 
age-damaged isoaspartyl residues back into normal amino acids. I studied the functional 
importance of PIMT in Schizosaccharomyces pombe, whose PIMT-encoding homolog is 
designated pcm2. Past studies of PIMT in other organisms had suggested that Pcm2p function 
could be important for viability under stress conditions. In the first part of the project, I 
compared the viability of a yeast strain lacking pcm2 (∆pcm2) under a variety of stress 
conditions, including stationary phase, heat shock, high-salt, high-sugar, high-pH, and high 
temperature. Based on studies of PIMT in other organisms, I expected to see reduced viability of 
the knockout strain during stress conditions, but no difference in cell growth or viability was 
observed. I also attempted to use Real-Time PCR to compare pcm2 transcription in yeast under 
the same stress conditions. I have not yet collected any usable data from the Real-Time PCR 
runs, but it has been previously shown that pcm2 transcription increases during stationary phase, 
heat shock, and osmotic shock. This increase in pcm2 transcription during stress with no 
phenotype associated with loss of pcm2 under stress conditions leads to the hypothesis that there 
may be a second gene whose product can compensate for loss of PIMT function. To locate and 
identify this gene, a synthetic lethal screen is being utilized. Currently, five potential synthetic 
lethal mutants have been isolated. 
 2 
Chapter 1: Introduction 
As proteins age, they undergo many different kinds of spontaneous modifications. These 
modifications can have various effects. Some might change the shape of the protein; others 
might compromise the protein’s function. One spontaneous modification is the generation of an 
L-isoaspartate from an L-aspartate or an L-asparagine (see Figure 1). This change is initiated by 
the nucleophilic attack of the adjacent downstream peptide bond nitrogen onto the side chain 
carbonyl carbon of an aspartate or asparagine. This produces a succinimide ring with two 
equivalent peptide bonds, which spontaneously hydrolyzes at one of the two bonds to produce 
either L-aspartate or L-isoaspartate (Geiger and Clarke 1987). The appearance of an isoaspartyl 
group introduces an extra carbon into the protein backbone, producing a kink in the protein 
structure that can interfere with normal folding and function. These damaged amino acids do not 
accumulate in cells, however, because cells have an isoaspartyl repair mechanism in place. 
Protein isoaspartyl methyltransferase (PIMT), the focus of my project, is an enzyme that uses S-
adenosyl-L-methionine (SAM) as the methyl donor to methylate the carboxyl group of the 
isoaspartyl residue (Johnson et al 1987). The resulting L-isoaspartyl methyl ester spontaneously 
demethylates to reform the succinimide ring, which again hydrolyzes at either peptide bond to 
give L-aspartate or L-isoaspartate (Johnson et al 1987; McFadden and Clarke 1987). The cycle 
of methylation and demethylation continues until all the L-isoaspartate has been converted into 
L-aspartate. The net result is the repair of the polypeptide backbone and the conversion of all 
isoaspartyl residues into aspartyl residues (Johnson et al 1987; Brennan et al 1994). The 
conversion of L-isoaspartate to L-aspartate allows the protein to regain much of the function that 
it had lost when the L-isoaspartate first appeared. This gain of function may not be complete if  
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Figure 1
PIMT-mediated protein repair. As proteins age, isoaspartyl residues are spontaneously generated from asparaginyl and aspartyl residues. 
Protein isoaspartyl methyltransferase (PIMT) initiates repair of this modification by catalyzing the methylation of isoaspartyl residues. The 
resulting isoaspartyl methyl ester spontaneously demethylates, and can then hydrolyze into an isoaspartyl or an aspartyl residue. The cycle of 
methylation and demethylation continues until all isoaspartate has been converted to aspartate. 
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the original damaged amino acid was asparagine, perhaps because any L-isoaspartate generated 
from L-asparagine becomes L-aspartate in this mechanism, changing the original sequence of the 
protein. 
PIMT enzymatic activity has been demonstrated in a wide variety of organisms, 
including bacteria, mollusks, fungi, plants, and vertebrates (Johnson et al 1991). In addition, 
genome-wide screens for sequences capable of encoding PIMT homologs have identified 
putative PIMT genes in many other species. Potential PIMT-encoding genes have now been 
found in all eukaryotes studied, except the budding yeast S. cerevisiae. Future studies of the 
enzymatic activities of proteins encoded by these genes may show that they do, in fact, code for 
PIMT. 
In more recent years, gene sequencing and various genome projects have allowed 
interspecies comparison of different PIMTs. Three highly conserved sequence motifs have been 
identified throughout SAM-dependent methyltransferases, which include PIMT as well as 
methyltransferases with a wide range of different substrate specificities (Kagan and Clarke 
1994). Because the common feature of these enzymes is their dependence on the cofactor SAM, 
it is hypothesized that the three conserved motifs are necessary for SAM binding (Kagan and 
Clarke 1994). 
Recently, these predictions have been confirmed by crystal structures of PIMTs from T. 
maritima, P. furiosus, D. melanogaster, and humans (Skinner et al 2000; Griffith et al 2001; 
Bennett et al 2003; Ryttersgaard et al 2002; Smith et al 2002). In addition to the SAM binding 
motifs, the crystal structures have revealed other conserved regions important for binding peptide 
substrates (Martin and McMillan 2002). 
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PIMT’s strong conservation throughout animal evolution suggests its importance for the 
viability of organisms, presumably as part of the cellular machinery that deals with protein 
damage. Experiments with various model organisms have been performed to test this hypothesis. 
In one such study, an E. coli PIMT-deficient mutant was created by homologous recombination. 
These mutant cells survive normally during both log phase and stationary phase. Their viability 
is reduced in stationary phase, however, when they are exposed to methanol, paraquat (an 
oxidative stressor), high salt concentration, or repeated high temperature (Visick et al 1998). This 
enhanced susceptibility to stresses shows the importance of PIMT during highly stressful 
conditions. 
In a similar study, a C. elegans PIMT-deficient mutant was constructed by transposon 
excision. Once again, these mutants grow and develop normally when compared to controls. 
However, when mutant worms enter the dauer stage in response to crowding or insufficient food 
supply, the mutants have a decreased survival rate and decreased fitness compared to control 
animals (Kagan et al 1997). As with E. coli, these results show the importance of PIMT during 
stress conditions. 
A more dramatic effect of PIMT deficiency was observed in mice. PIMT-deficient 
animals were constructed by targeted disruption of the PIMT in embryonic stem cells, which 
were then used to produce transgenic animals. The PIMT-deficient mouse exhibits a smaller size, 
a larger brain, and the appearance of juvenile epilepsy, leading to an early death from seizures 
(Kim et al 1997; Yamamoto et al 1998). PIMT deficiency also leads to an increased 
accumulation of isoaspartyl proteins in various tissues, including the brain; it is hypothesized that 
this accumulation of damaged proteins may lead to the fatal epilepsy (Kim et al 1997). 
Unfortunately, since these mice die so early, they are not useful for studying the relationship 
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between PIMT activity and lifespan. These deficits are partially rescued by a transgene that 
allows PIMT transcription specifically in neural tissue, under the control of a neuron-specific 
enolase promoter. In rescued mice, the lifespan of the mouse increases to a level intermediate to 
those of the deficient mouse and the normal mouse, and the size of the rescued mouse is the 
same as the size of the normal mouse (Lowenson et al 2001). In nonneural tissues of these 
transgenic PIMT-deficient mice, levels of isoaspartyl proteins were also 5-fold higher than in 
control animals, yet no apparent defects were found in these tissues, which included the heart, 
testes, and erythrocytes (Lowenson et al 2001). Thus, damage associated with PIMT loss may be 
restricted to the brain in mammals. 
The effects of PIMT overexpression have been studied in the fruitfly Drosophila 
melanogaster. The lifespan of flies ubiquitously overexpressing PIMT at 3-7 times the normal 
level increased 32-39 % relative to controls. Lifespan extension was observed when the flies 
were reared at 29 ˚C but not when the flies were reared at the normal 25 ˚C (Chavous et al 2001). 
These PIMT overexpressing flies also showed increased locomotor activity relative to controls, 
throughout the lifespan (Chavous et al 2001). These results once again suggest that PIMT is not 
necessary for survival at normal conditions, but becomes more important under stress conditions. 
At the higher temperatures where PIMT extends lifespan, proteins would be more 
conformationally flexible and susceptible to isoaspartate formation. 
The subtle effects observed in most PIMT deletions suggest that other activities may 
compensate for loss of PIMT function in cells. In this study, I use the fission yeast S. pombe, 
which represents a simple tractable model for studying genetic interactions, to study PIMT 
function and identify other activities which might substitute for PIMT function. The S. pombe 
homolog of PIMT, Pcm2p, has been shown to be biochemically similar to other PIMTs. Kinetic 
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data obtained from Pcm2p methylation of ovalbumin (an isoaspartyl-containing substrate) has 
shown that Pcm2p acts in the same way as other PIMTs (Plodkowski, unpublished data). 
Recent genome-wide studies of transcription suggest several situations where Pcm2p 
function may be especially important. One microarray study characterized the transcriptional 
regulation of S. pombe genes during meiosis and sporulation, which happen under conditions of 
nutritional stress. This study found pcm2 transcription to increase over 20-fold following the 
meiotic divisions and as the yeast began sporulation (Mata et al 2002). A second study used 
microarrays to characterize transcriptional responses to various other stresses. This study showed 
that pcm2 transcription increases over 5-fold in 60 minutes after heat shock to 39 ˚C (Chen et al 
2003). These results suggest that, just as in other organisms where PIMT seems to be important 
under stress conditions, Pcm2p may be important for S. pombe survival under stress. Northern 
blot experiments in our lab further support this idea by demonstrating a large increase in pcm2 
transcription during stationary phase. Moreover, it was shown that pcm2 transcription increases 
even more when the stress of stationary phase is combined with the stresses of heat shock to 
37˚C or osmotic shock (Northern, unpublished data). 
 A pcm2 deficient yeast strain (APP1) has been created by homologous recombination in 
which a ura+ gene replaced the endogenous pcm2 gene (Plodkowski, unpublished data). This 
∆pcm2 strain is viable and does not show any difference in growth during log phase, or under 
various stress conditions including low or high pH, various high temperatures, or high salt 
conditions (Northern, unpublished data). The increased transcription of pcm2 during stress 
conditions with no decreased viability for yeast lacking Pcm2p during those same conditions 
leads us to hypothesize that a second gene may be compensating for the loss of Pcm2p function.  
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 To find this gene, I am performing a synthetic lethal screen. The strain for this screen, 
LNP35t, has been constructed previously (Northern, unpublished data). LNP35t was originally 
pcm2-deficient but contains a plasmid carrying the pcm2 gene. In the synthetic lethal screen, 
LNP35t is treated with a mutagen and cells are screened to find a mutant which became 
dependent on pcm2 as a consequence of losing the other gene that normally compensates for loss 
of pcm2. If this is the only redundant gene, the double mutant would then be dependent on the 
pcm2-containing plasmid for survival, so the cells are screened for those that do not lose the 
plasmid. My goal is to identify any compensatory genes by mutagenesis and screening, and 
eventually characterize them. 
 In addition, I have investigated two other questions: how does the transcription of pcm2 
vary under different stress conditions?; are there phenotypic effects of loss of pcm2? For the first, 
I compare wild-type transcription of pcm2 during regular log phase growth and under the 
following stress conditions: stationary phase growth, long-term heat shock, short-term heat 
shock, high-sugar, high-salt, high pH. I use Real-Time RT-PCR to determine relative levels of 
pcm2 for each condition. For the second question, I study the ∆pcm2 strain, APP1, further to 
identify any effects of pcm2-deficiency. Namely, I compare growth of APP1 to that of wild-type 
yeast during long-term stationary phase culture at normal and elevated temperatures. Also, I 
compare the growth of APP1 to that of wild-type yeast during the following stress conditions: 
high-sugar, high-salt, high pH, and each of these combined with elevated temperature. 
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Chapter 2: Materials and Methods 
Materials: 
Reagent-grade chemicals and glass beads (425-600 microns) were purchased from Sigma 
Chemical Company (St. Louis, MO) unless otherwise stated. Granulated agar for solid media, 
glass beads (4 mm), and culture plates were purchased from Fisher (Pittsburg, PA). Conical 
tubes were purchased from Becton Dickinson (Franklin Lakes, NJ). SeaKem GTG agarose for 
nucleic acid gels was purchased from BioWhittaker Molecular Applications (Rockland, ME). 
Yeast extract, casamino acids, and malt extract were purchased from Difco (Detroit, MI). Tris-
HCl was purchased from Polyscience, Inc. (Warrington, PA). Positively charged nylon 
membranes were purchased from Roche (Indianapolis, IN). Hyblot 3A gel paper was purchased 
from Denville Scientific (South Plain, NJ). The DECAprime II kit and DNA-freeTM Dnase 
treatment and removal kit were purchased from Ambion Corporation (Austin, TX). Micro-
columns were purchased from Amersham Biosciences (Piscataway, NJ). Film was purchased 
from Eastman Kodak Company (Rochester, NY). Cronex Lightning Plus intensifying screens 
were purchased from DuPont Corporation (Wilmington, DE). Electrophoresis equipment and 
reagents, the iScript cDNA synthesis kit, the iQ SYBR Green Supermix for Real-Time PCR, and 
96-well PCR plates were purchased from Bio-Rad (Hercules, CA). [α-32P]dCTP was purchased 
from Perkin-Elmer (Branchburg, NJ). TaqProTM Complete DNA Polymerase mix, 2.0 mM 
MgCl2 was received as a sample from Denville Scientific Inc. (Metuchen, NJ). MicroAmp 
reaction tubes were purchased from Applied Biosystems (Foster City, CA). Oligonucleotides 
were purchased from MWG Biotech (High Point, NC). 
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Yeast Strains: 
Strain Mating 
Type 
Genotype Plasmid 
975 h+ wt  
AP77 h- ade1 ade6-M210 leu1 ura4  
APP1 h+ ura4-D18 pcm2::ura4+  
CLP01 h+ leu1-32 pNMT:pcm2/Leu2 
FWP10 h- Wt  
FWP16 h+ ura4-D18  
KBP4 
KBP5 
KBP6 
KBP7 
KBP8 
h- ade1 ade6-M210 leu1-32 ura4-D18 
pcm2::ura4+ 
mutX- 
pNPT/ADE1-3/pcm2 
KHP01 h+ leu1-32 ura4-D18 pcm2::ura4+ pNMT:pcm2/Leu2 
LNP25 h- ade1 ade6-M210 leu1-32 ura4-D18 
pcm2::ura4+ 
 
LNP35t h- ade1 ade6-M210 leu1-32 ura4-D18 
pcm2::ura4+ 
pNPT/ADE1-3/pcm2 
 
Media: 
Yeast were grown in various liquid and solid media, with compositions as follows: 
YEL liquid: 5 g/L yeast extract, 2 g/L casamino acids, 30 g/L glucose 
YEA solid: 5 g/L yeast extract, 2 g/L casamino acids, 30 g/L glucose, 20 g/L agar 
YEA +adenine solid: YEA solid with 100 mg/L adenine 
YEA +adenine +geneticin solid: YEA +adenine solid with 100 mg/L geneticin added after 
autoclaving and cooling 
MEA solid: 30 g/L malt extract, 4 g/L glucose, 20 g/L agar 
PM complete liquid: 3 g/L phthallic acid, 3.4 g/L sodium phosphate, 5 g/L ammonium chloride, 
30 g/L glucose, 20 ml/L PM salts, 75 mg/L histidine, 75 mg/L uracil, 75 mg/L adenine,  
150 mg/L leucine. The solution was brought to pH of 5.6 using 1 M KOH and autoclaved. After 
cooling, 1 mL/L PM vitamins and 0.1 mL/L PM minerals were added. 
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PM –leucine liquid: PM complete liquid without leucine 
PM complete solid: 3 g/L phthallic acid, 3.4 g/L sodium phosphate, 5 g/L ammonium chloride, 
30 g/L glucose, 20 ml/L PM salts, 75 mg/L histidine, 75 mg/L uracil, 75 mg/L adenine,  
150 mg/L leucine, 20 g/L agar. The solution was brought to pH of 5.6 using 1 M KOH and 
autoclaved. After cooling, 1 mL/L PM vitamins and .1 mL/L PM minerals were added. 
PM minimal liquid: PM complete liquid without histidine, uracil, adenine, leucine 
PM minimal solid: PM complete solid without histidine, uracil, adenine, leucine 
PM –uracil solid: PM complete solid without uracil 
PM –leucine solid: PM complete solid without leucine 
PM –leucine –adenine solid: PM complete solid without leucine or adenine 
PM complete +geneticin solid: PM complete solid with 100 mg/L geneticin added after 
autoclaving and cooling 
PM complete, pH 6.9, liquid: PM complete liquid, brought to a pH of 6.9 using 1 M KOH before 
autoclaving 
PM -leucine, pH 6.9, solid: PM -leucine solid, brought to a pH of 6.9 using 1 M KOH before 
autoclaving 
PM complete, 1 M KCl, liquid: PM complete liquid with 74.6 g/L KCl added with PM salts 
PM -leucine, 1 M KCl, solid: PM -leucine solid with 74.6 g/L KCl added with PM salts 
PM complete, 1.6 M sorbitol, liquid: PM complete liquid with 291.5 g/L sorbitol added with 
glucose 
PM -leucine 1.6 M sorbitol, solid: PM -leucine solid with 291.5 g/L sorbitol added with glucose 
PM salts: 53.5 g/L magnesium chloride, .75 g/L calcium chloride, 50 g/L potassium chloride,  
2 g/L sodium sulfate. This solution was filter sterilized and stored at 4 ˚C. 
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PM vitamins: 1 g/L pantothenic acid, 10 g/L nicotinic acid, 10 g/L inositol, 10 mg/L biotin. This 
solution was filter sterilized and stored at 4 ˚C. 
PM minerals: 5 g/L boric acid, 4 g/L manganese sulfate, 4 g/L zinc sulfate, 2 g/L ferrous 
chloride, 1.6 g/L molybdic acid, 1 g/L potassium iodide, .4 g/L copper sulfate, 1 g citric acid. 
This solution was filter sterilized and stored at 4 ˚C. 
Liquid Cultures: 
To obtain a log phase culture, the following procedure was followed: A single colony of 
cells was cultured in 3-5 mL of PM complete liquid media at 30 ˚C. This was left to grow 
overnight to a density of at least 107 cells/mL. The cells were counted in a hemacytometer and 
diluted to a density between 106 - 5 x 106 cells/mL in the appropriate liquid medium. Cultures 
were then incubated at 30 ˚C with constant shaking at 220 RPM until they reached the desired 
densities. 
Mutagenesis: 
Log phase cultures, grown with geneticin to ensure plasmid retainment, were counted in a 
hemacytometer and resuspended in 1.5 mL PM Complete liquid media to a concentration of  
1.33 x 108 cells/mL. These cells were washed with 1 mL 10 mM KH2PO4, pH 7.0, and 
resuspended in 1.5 mL of this same buffer. A 1.0 mL aliquot of this was removed to a fresh tube 
and mixed with a specified amount of ethylmethanesulfate. The tube was shaken at 30 ˚C for 
various times as indicated in the text, after which a 0.25 mL aliquot of the solution was 
transferred to a new tube and mixed with 1 mL 5 % sodium thiosulfate to stop the reaction. The 
cells were centrifuged and washed twice with 1 mL sterile water and once with 1 mL YEA liquid 
media. Cells were counted with a hemacytometer. Specified dilutions of the cells were then 
plated on YEA solid media using glass beads. 
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Rapid Transformation of S. pombe: 
A large patch of cells was grown on PM complete solid media at 30 ˚C. This patch was 
then scraped into a tube containing 2 µL plasmid (0.5 µg – 1 µg) and 0.3 mL of PLATE buffer 
(40.5 % PEG-4000; 10 mM Tris-HCl, pH 7.5; 100 mM LiAc; 1 mM EDTA, pH 8.0) and 
incubated overnight at room temperature. Settled cells were then plated onto the appropriate 
selective solid medium. 
RNA isolation: 
RNA was isolated by a modification of the procedure described by Schmitt et al (1990). 
Cells were centrifuged at 2000 g for 5 minutes and resuspended in 400 µL of AE buffer (50 mM 
Na acetate, pH 5.3; 10 mM EDTA). The suspension was transferred to a screw cap microfuge 
tube, along with a volume of small glass beads equal to the size of the pellet of cells. Forty µL of 
10 % SDS and 440 µL of phenol were added, and the tube was immediately vortexed and 
incubated at 65 ˚C for 4 minutes. The cells were then placed on dry ice until phenol crystals 
formed. The suspension was separated by centrifuging at 13,000x g for two minutes. The upper, 
aqueous layer was transferred to a new tube, and two extractions were performed with 400 µL 
1:1 phenol:chloroform, followed by an extraction with 400 µL chloroform. The RNA was 
precipitated by adding 40 µL 3 M Na acetate, pH 5.3, and 1 mL ice-cold 95 % ethanol. This was 
stored at –20 ˚C for at least 1 hour. The suspension was centrifuged at 4 ˚C for 15 minutes to 
pellet the RNA. The pellet was then washed with 500 µL ice-cold 80 % ethanol and resuspended 
in 20 µL RNase-free sterile water. 
RNA electrophoresis and Northern blot: 
The gel apparatus was rinsed with DEPC-treated water to inactivate any associated 
RNase. A gel was prepared containing 0.25 g agarose in 15.5 mL DEPC-treated water, plus 5 mL 
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5 X MOPS buffer (0.2 M MOPS, pH 7.0; 50 mM Na acetate; 5 mM EDTA, pH 8.0) and 4.42 mL 
formaldehyde. Each RNA sample was prepared by mixing 1 – 5 µL RNA (5 – 20 µg RNA) with 
5 µL formamide, 2 µL formaldehyde, 1 µL 5 X MOPS buffer, and 1 µL 400 µg/mL ethidium 
bromide. The samples were incubated at 65 ˚C for 10 minutes and placed on ice. A 2 µL aliquot 
of sterile loading buffer (50 % glycerol; 1 mM EDTA; 0.4 % bromophenol blue; 0.4 % xylene 
cyanol) was then added to each sample and the gel was run using 1 X MOPS buffer as the 
running buffer. 
RNA was transferred to a positively charged membrane using the PosiBlot 30 – 30 
Pressure Blotter and Pressure Control Station. After transfer, the RNA was cross-linked to the 
membrane with 1200 µjoules of ultraviolet radiation. Hybridization probes were labeled by 
random priming, using the DECAprime II kit, with [α-32P]dCTP. The reaction mixture was 
centrifuged through a ProbeQuant G-50 micro column to remove unincorporated nucleotides 
from the probe. The membrane was prepared for hybridization by incubating it in a hybridization 
tube for 1 hour at 65 ˚C, in prehybridization solution (0.5 M sodium phosphate pH 7; 1 mM 
EDTA; 7 % SDS, 1 % BSA fraction V, 100 µg/mL salmon sperm DNA). The probe was then 
added and the tube was incubated overnight at 65 ˚C. The membrane was then washed with wash 
buffer (40 mM sodium phosphate; 1 mM EDTA; 1 % SDS) twice for 15 minutes and twice for 
60 minutes. The membrane was put in a film cassette with Kodak Biomat MS film and an 
intensifying screen, and the cassette was stored at –80 ˚C for three weeks. The film was then 
developed using the X-O-mat machine. 
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 Chapter 3: Analysis of wild-type S. pombe pcm2 RNA expression 
 Based on the evidence in other organisms that PIMT is important during stress 
conditions, as well as the evidence suggesting this so far in S. pombe, we expect pcm2 expression 
to increase during stress conditions. Previous experiments in our lab used Northern blots to show 
that pcm2 expression increases during stationary phase growth, as well as during heat or osmotic 
shock. My goal is to expand on these experiments by using Real-Time RT-PCR to quantitively 
analyze 975 (wild-type) pcm2 expression during a wider range of stress conditions. Real-Time 
PCR is a useful technique because it makes it very easy either to compare expression of a single 
gene across many different samples or to analyze the expression of multiple genes using a single 
RNA sample. PCR mix can be purchased containing a dye, SYBR Green, that fluoresces when 
bound to double-stranded-DNA. Then, as amplification progresses during the PCR, there is more 
dsDNA for the SYBR Green to bind to, and total fluorescence increases. The Real-Time machine 
measures fluorescence at each cycle and displays the data in terms of relative fluorescence units. 
Levels of initial cDNA, and therefore initial RNA, present in samples are compared using the 
“threshold value,” or the number of cycles necessary to get relative fluorescence at 10 times the 
baseline level. Thus, I expect to see lower threshold values for stress condition samples, meaning 
that they have more initial pcm2 transcripts. 
The main steps of this process are: 1) RNA extraction from yeast samples; 2) DNase 
treatment to remove genomic DNA contamination; 3) reverse transcriptase reaction; 4) Real-
Time PCR reaction and analysis. Currently, steps 1-3 have been completed successfully, and I 
am still working on step 4. 
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RNA extraction: 
I extracted RNA from strain 975 cells under each of the following conditions: log phase 
growth, stationary phase growth, short-term heat shock, long-term heat shock, 1.6 M sorbitol,  
1 M KCl, and pH 6.9 (see Figure 2). Here, log phase growth was used as a control, and each of 
the stress condition cultures, except for the stationary phase culture, consisted of cells in log 
phase. The heat shock stress conditions were achieved by incubating the cultures at 37 ˚C instead 
of at 30 ˚C – the long-term heat shock culture was placed at 37 ˚C from the very beginning of the 
starter culture, while the short-term heat shock culture was placed at 37 ˚C for only 1 hour before 
the extraction. The 1.6 M sorbitol, 1 M KCl, and pH 6.9 stress conditions were achieved by 
incubating cells in PM complete media with these additions. The extraction was performed as 
described. Spectrophotometer readings at 260 nm were used to determine the concentrations of 
RNA in the various extracts. The samples were run on a denaturing gel as described to confirm 
the presence of RNA and its integrity (see Figure 3). The apparent sizes of the ribosomal RNA 
bands for all seven samples agree nicely with the published rRNA sizes of 3.5 and 1.8 kb. 
The amount of RNA extracted from each cell ranged from 5.47 * 10-8 – 4.94 * 10-7 µg. 
This is much less than the known RNA content for a yeast cell, which is approximately 3 pg, or  
3 * 10-6 µg. The basis for the low efficiency of the extraction is not known. The poor yield could 
be due to the toughness of the yeast cell wall. Even though hot phenol and glass beads are used 
in the extraction to break through the cell wall, these extreme treatments may not be sufficient to 
disrupt all cells. If fewer than all of the cells are broken up, the amount of RNA extracted will be 
lower than expected. Yeast cells in stationary phase have particularly tough cell walls, as the 
cells are not dividing in stationary phase. This may explain why the yield of RNA from the 
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Figure 2 
 
 
 
 
 
Summary of RNA extractions from wild type (strain 975) cells at various conditions. 
 
sample
condition
media (all are
liquid)
temperature
(ÞC)
density of culture
(cells/mL)
# cells used
for extraction
total RNA
extracted (µg)
RNA extracted
per cell (µg/cell)
log phase PM complete 30 8.25 * 106 3 * 108 91.2 3.04 * 10-7
stationary
phase
PM complete 30 1.41 * 108 3 * 108 16.4 5.47 * 10-8
1.6 M
sorbitol
PM complete
+1.6 M sorbitol
30 7.83 * 106 3 * 108 104.8 3.49 * 10-7
1 M KCl PM complete
+1 M KCl
30 5.8 * 106 8.64 * 107 31.1 3.60 * 10-7
pH 6.9 PM complete
pH 6.9
30 8.17 * 106 3 * 108 148.2 4.94 * 10-7
heat shock
– long
term
PM complete 37 1.27 * 107 3 * 108 139.8 4.66 * 10-7
heat shock
– short
term
PM complete 30, moved to 37
for 1 hour before
extraction
1.3 * 107 3 * 108 81 2.7 * 10-7
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Figure 3 
a. b. 
RNA extracted from 975. a) Lane A -standard marker; Lane B - log phase growth; Lane C - heat shock, short-term; Lane D - 1.6 M 
sorbitol; Lane E - 1 M KCl; Lane F - pH 6.9; b) Lane A - standard marker; Lane B - stationary phase growth; Lane C - heat shock, 
long-term 
A B C FED
3.6 kb 
1.9 kb 
1.9 kb
3.6 kb
A B C
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stationary phase sample is a full order of magnitude lower than the yields for all of the other log 
phase samples. 
DNase treatment: 
 After an RNA extraction, there is frequently some amount of genomic DNA left in the 
solution of RNA. Even small amounts of genomic DNA can obscure the PCR results of the 
cDNA you actually want to amplify. I used the DNA-freeTM DNase treatment kit, which consists 
of a treatment buffer, a DNase, and a DNase-inactivation reagent, to treat each of my samples. 
The samples in Figure 3 were analyzed prior to DNase treatment. The presence of high-
molecular-weight material in the samples in panel b is consistent with some DNA contamination 
in the stationary phase and long-term heat shock samples. The absence of such high-molecular-
weight bands in panel a does not exclude possible DNA contamination. Therefore, I treated  
1-3 µL of each RNA sample with DNase, to yield final DNA-free RNA solutions with 
concentrations ranging from 0.084 – 0.15 µg/µL. 
Reverse transcriptase reaction: 
 I used the iScript cDNA synthesis kit to reverse-transcribe the RNA into cDNA. This kit 
consists of a reaction mix, containing buffer, nucleotides, and oligo and hexamer random 
primers, and a reverse transcriptase. I used 1 µg of RNA in each sample, including a control 
reaction, which lacked reverse transcriptase, for each sample. 
 
Real-Time PCR: 
 Primers for the RT-PCR, SP24 and SP25, were designed using the Beacon Designer 2 
program (Premier Biosoft International; Palo Alto, CA). The expected product size with these 
primers is 188 bp. The forward primer, SP24, has a sequence of  
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5’-ACGAATCAGAGAGCCATCAAG-3’.The reverse primer, SP25, has a sequence of  
5’- CCAATATCCAAGGCAGAACAG-3’. 
The first step to this was to determine an optimal PCR protocol. To do this, I ran a normal 
PCR on two RT samples – log phase growth and heat shock, long-term – as a text. I set up each 
reaction using the TaqPro PCR mix according to manufacturer’s instructions and the SP24 and 
SP25 primers at a final concentration of 2 µM, along with 1 µL of the RT sample. For the 
amplification, I used a 5 minute initial denaturation, forty amplification cycles (95 ˚C-1 min., 55 
˚C-2 min., 72 ˚C-3 min.), and a final extension at 72 ˚C for 7 minutes. Electrophoresis on a 1.5 % 
agarose gel confirmed that a product of the correct size was formed in each reaction. 
 Once I knew that these conditions did allow for amplification by these primers, I did two 
runs of Real-Time PCR on my RT samples. In addition to running PCR reactions of my samples, 
I did several controls: a positive control, using the plasmid pNPT/ADE1-3/pcm2; a negative 
control, with water in place of any sample; seven more negative controls, in which reverse 
transcriptase had been omitted (in the first run, I used only the –RT log phase growth control; in 
the second run, I used all –RT samples). I set up reactions using the iQ SYBR Green Supermix 
according to manufacturer’s instructions and the SP24 and SP25 primers at a final concentration 
of 2 µM. I used the same PCR protocol as above (see Figure 4.a), and following the Real-Time 
PCR, I ran an aliquot of each sample from the PCR well on a 1.5 % agarose gel to confirm the 
Real-Time results (see Figure 4.b). 
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Figure 4
Real-Time PCR summary. a) # of cycles vs. relative fluorescence units with baseline 
amounts subtracted; table of threshold values; b) gel of samples (standard marker X is seen on 
both ends of the gel) 
 
A1 - log phase growth, A2 - plasmid control, B1 - stationary phase growth, B2 - water control, 
C1 - heat shock short-term, D1 - 1.6 M sorbitol, E1 - pH 6.9, F1 - 1 M KCl, G1 - heat shock 
long-term, H1 - -RT log phase growth control 
a. 
220/201 bp 
154/134 bp 
b. A1  B1  G1 C1 D1  F1 E1 H1 A2 B2
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I expected the two negative controls (water and –RT) to have the least amplification and 
therefore the highest threshold values, the positive control (pNPT/ADE1-3/pcm2) to have the 
most amplification and the lowest threshold value, and the seven samples to have amplification 
and threshold values in between those of the negative and positive controls. However, according 
to the Real-Time data, the positive control plasmid sample had the least amplification, indeed, 
showing almost none at all. The –RT log phase growth control sample showed the most 
amplification. Each of the other samples was somewhere in between, but for six of the seven RT 
samples, amplification was quite low. Also, the threshold cycle value for each sample was very 
similar, with all threshold cycle values ranging only from 20.7-23.2, except for the plasmid 
control, which was not assigned a threshold cycle value. 
 On the other hand, according to the gel, the plasmid sample certainly had a lot of 
amplification, while the –RT control had practically none. Each of the seven RT sample lanes 
also showed a product band. Since, for example, the sample with the lowest amplification 
according to the Real-Time data (plasmid control) was taken directly from that well and run on a 
gel, where it showed a significant DNA band, I know that the Real-Time output is incorrect. I 
hypothesize that the Real-Time machine was either misreading the fluorescence or 
misinterpreting the data. When the Real-Time PCR was repeated, similar results were obtained. 
This leaves me with no usable results on the relative expression of pcm2 during various stress 
conditions. I am currently in the process of working out this problem. 
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Chapter 4: Effects of loss of pcm2 in S. pombe 
As discussed earlier, loss of PIMT is known to cause observable phenotypic changes in 
several organisms, including E. coli, C. elegans, and mice. Phenotypes appear when the 
organism is under stress conditions. Earlier work in our lab established that loss of PIMT activity 
did not affect vegetative growth in yeast. My goal is to determine the effect of PIMT loss on cell 
growth and viability under various stress conditions. For these experiments, I chose to use spot 
plates to assess viability. Spot plates are useful because they allow you to compare growth of 
several strains on the same plate. Viability is assessed by qualitatively comparing spot density 
and size, rather than counting individual cells or comparing growth in streaks. I also kept records 
of cell growth/viability by taking pictures of the plates. 
Stationary Phase Survival: 
 Work from other organisms suggested that PIMT deficiency might reduce the ability of 
cells to survive in stationary phase. In this new experiment, relative cell viability was determined 
by plating cells at various timepoints after they entered stationary phase. 
I first compared the survival of the pcm2-knockout strain, APP1 (ura4-D18; 
pcm2::ura4+), to that of the wild-type strain FWP10 and that of FWP16 (ura4-D18), the parental 
strain for APP1. For each yeast strain, starter cultures were initially diluted in PM Complete 
liquid media to give a 10 mL culture with cell density of 2 * 106 cells/mL. One culture was then 
incubated continuously at 30 ˚C and the other was incubated at 36 ˚C, with constant shaking. 
Cells in all cultures entered stationary phase within the first day of incubation. Cell densities 
ranged from 7.7 * 107 – 1.76 * 108 initially and stayed more or less constant throughout the 
experiment. 
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Viability was assessed every day for the 36 ˚C cultures, and on days 1, 7, 10, and then 
every other day for the 30 ˚C cultures. To assess viability, cultures were first counted in triplicate 
in the hemacytometer to obtain cell density. Then, a series of 1:5 dilutions was prepared in PM 
Complete liquid media, such that the first dilution contained 1 * 107 cells/mL (experiment 1) or  
2 * 107 cell/mL (experiment 2), and the final dilution contained 1.6 * 104 cells/mL (experiment 
1) or 1.28 * 103 cells/mL (experiment 2). An aliquot of each dilution (10 µL for experiment 1,  
5 µL for experiment 2) was plated on YEA solid media, and the plates were then incubated at  
30 ˚C. After three days of growth, pictures were taken of the plates. 
The first run of this experiment (see Figure 5.a) showed that at 36 ˚C, some cells from all 
three strains were still viable at 4 days, but no viable cells remained at 5 days. At 30 ˚C (see 
Figure 6.a), FWP16 cell viability was lost by 26 days. By day 32, APP1 cell viability was also 
lost, and only a few viable FWP10 cells were remaining. FWP16 probably lost viability first 
because it is a uracil auxotroph, while both APP1 and FWP10 have functional ura4+ genes. Thus, 
the first experiment indicates that, compared to the wild-type control FWP10 strain, loss of pcm2 
does not negatively affect the viability of APP1 in stationary phase at 36 ˚C, but may slightly 
reduce the viability of APP1 at 30 ˚C. 
When the experiment was repeated, FWP16 cells lost viability between 3 and 5 days at 
36 ˚C, while FWP10 and APP1 cells lost viability between 5 and 7 days (see Figure 5.b). At  
30 ˚C, a loss in FWP16 viability was apparent at 20 days, and no viable FWP16 cells remained at 
30 days. The loss of viability of wild-type and knockout cells occurred later, such that no viable 
FWP10 or APP1 cells were detected at 34 or 36 days, respectively (see Figure 6.b). As in the 
first experiment, FWP16 probably lost viability first because of its inability to synthesize uracil, 
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Figure 5 
a. 
b. 
Stationary phase survival of APP1, FWP10, and FWP16 at 36 ˚C. (a) first experiment - top line: APP1, middle line: 
FWP10, bottom line: FWP16, (b) second experiment - top line: FWP10, middle line: FWP16, bottom line: APP1 
Day 0 Day 2 Day 4 Day 5
Day 1 Day 3 Day 5 Day 7
APP1 
FWP10 
FWP16 
APP1 
FWP16 
FWP10 
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Figure 6 
a. 
b. 
Stationary phase survival of APP1, FWP10, and FWP16 at 30 ˚C. (a) first experiment - top line: APP1, middle line: FWP10, 
bottom line: FWP16, (b) second experiment - top line: FWP10, middle line: FWP16, bottom line: APP1 
Day 0 Day 17 Day 26 Day 32
Day 1 Day 20 Day 30 Day 34
FWP10 
FWP16 
FWP10 
FWP16 
APP1 
APP1 
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and loss of pcm2 did not affect viability at 36 ˚C. In contrast to the first experiment, however, 
APP1 survived slightly longer in stationary phase at 30 ˚C than FWP10 did. 
These two experiments fail to show a significant, reproducible difference in the survival 
of APP1 and FWP10 in stationary phase. Because of this, I conclude that loss of pcm2 does not 
directly affect survival of yeast in stationary phase, either at 30 ˚C or at the stress temperature of 
36 ˚C. 
Stress Condition Survival: 
 I also used the spot plate method to compare APP1 survival under various stress 
conditions to that of wild-type strain 975 and to two Pcm2p-overexpressing strains, CLP01 and 
KHP01. Strains CLP01 and KHP01 were constructed by transforming a pNMT:pcm2/Leu2 
plasmid into strains with wild-type or nonfunctional pcm2 genes. Here I hypothesized that APP1 
would grow less well than strain 975 under stress conditions, and that the overexpression strains 
would grow as well or better than strain 975. 
 In the first experiment, I grew cultures of APP1, 975, and CLP01 (leu1-
32;pNMT:pcm2/Leu2) in PM -leucine liquid media to mid-log phase. Cell densities were 
determined by counting in the hemacytometer and spot plates were done on control PM –leucine 
media, as well as on a variety of the same media modified to induce stress responses. Modified 
media contained 1.6 M sorbitol, 1 M KCl, or additional base to bring the pH to 6.9. Each spot 
plate contained a 10-fold dilution series for each strain, with cell numbers ranging from 1.2 *104 
cells/spot to 12 cells/spot. Duplicate plates were incubated for three days at 30 ˚C and 37 ˚C. The 
37 ˚C plates add a second stress associated with high temperature (see Figure 7). 
 There was very little difference in growth between APP1 and 975 cells on all plates. On 
the other hand, CLP01 grew consistently less well than the other two, despite its increase in  
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Control
1.6 M Sorbitol
1 M KCl
pH 6.9 
Growth of 975, APP1, and CLP01 under various stress conditions, at 30 ˚C (left) and 37 ˚C (right). On 
each plate, the top row of spots is 975, the middle row is APP1, and the bottom row is CLP01. 
Figure 7 
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pcm2 expression. It is not clear if the reduced viability of CLP01 is related to leucine auxotrophy 
or to high levels of protein expression from the plasmid. 
There were also several interesting results unrelated to the level of pcm2 expression. 
Surprisingly, cells grew better at 37 ˚C in the presence of either 1.6 M sorbitol or 1 M KCl, 
suggesting some crossprotection from osmotic and heat shocks. Growth at pH 6.9 was only 
detected in cells at high density, suggesting that metabolic byproducts may condition the media 
locally, allowing growth to occur there. 
 The experiment in Figure 7 was repeated with a new overexpressing strain, KHP01, 
which displayed better growth properties than CLP01 under permissive conditions. The 
endogenous pcm2 gene of KHP01 had been replaced with a ura4+ gene. In the second 
experiment, cultures of 975, APP1, and KHP01 (ura4-D18;leu1-32;pcm2::ura4+; 
pNMT:pcm2/Leu2) were grown in PM –leucine liquid media to mid-log phase. Densities were 
determined with the hemacytometer and spot plates on the same control and stress media were 
done using a 10-fold dilution series, with cell numbers ranging from 1.07 * 104 cells/spot to 10 
cells/spot. The plates were also incubated at both 30 ˚C and 37 ˚C for three days (see Figure 8). 
 The results in the second experiment are almost identical to those from the first 
experiment. These plates once again show similar growth between strains APP1 and 975. Strain 
KHP01 grew less well than the other two, suggesting that the reduced growth is not due to 
differences in genetic background between CLP01 and KHP01. 
 Both experiments fail to show any difference in growth between pcm2-knockout APP1 
and wild-type 975 under stress conditions. These results suggest either that pcm2 is not involved 
in stress responses or that S. pombe may carry a second gene that compensates for loss of pcm2. 
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Control
1.6 M Sorbitol
1 M KCl
pH 6.9 
Growth of 975, APP1, and KHP1 under various stress conditions, at 30 ˚C (left) and 37 ˚C (right). 
On each plate, the top row of spots is 975, the middle row is APP1, and the bottom row is KHP1. 
Figure 8 
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Chapter 5: Synthetic Lethal Screen 
Since no phenotype has been identified yet for strains lacking pcm2, we hypothesize that 
there may be other genes whose products compensate for the loss of Pcm2p. My goal is to 
identify this gene or genes with a synthetic lethal screen. The main steps of this screen are:  
1) creation of a pcm2-knockout yeast strain with appropriate markers; 2) transformation of this 
strain with a pcm2-carrying plasmid; 3) mutagenesis of this transformed strain; 4) screening of 
mutagenized cells for potential synthetic lethal strains; 5) backcrossing synthetic lethal strains 
into a uniform genetic background; 6) identification of mutant alleles by complementation. 
Currently, steps 1-4 have been performed. I am in the process of repeating steps 3 and 4 to get a 
few more potential synthetic lethal strains before moving on to step 5. 
Previously, a strain for mutagenesis, LNP35t, was constructed (step 1). To do this, APP1, 
the pcm2-knockout strain, was mated with AP77 to introduce selective markers. The resulting 
strain, LNP25, was transformed with the pNPT/ADE1-3/pcm2 plasmid (step 2), to give LNP35t. 
Confirmation of pcm2 expression in LNP35t: 
The success of the synthetic lethal screen is dependent upon successful production of 
Pcm2p in LNP35t. It is also critical that the only source of Pcm2p is the pNPT/ADE1-3/pcm2 
plasmid. Our lab has previously shown that APP1 lacks pcm2 transcripts (Northern, unpublished 
data). Since APP1’s pcm2::ura4+ mutation was selected for in the mating that produced 
LNP35t, we know that LNP35t lacks a genomic copy of pcm2. Thus, my first goal was to show 
that LNP35t produces pcm2 transcripts, which we would assume to be coming from the plasmid. 
This would ensure that both of the above-mentioned conditions were met before beginning the 
mutagenesis. 
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To verify pcm2 expression, I did a Northern blot of RNA extracted from both log and 
stationary phase LNP35t cells. Cultures of LNP35t were grown in PM complete liquid media at 
30 ˚C to a density of 3.75 * 106 cells/mL for the log phase culture and 8.8 * 107 cells/mL for the 
stationary phase culture. Suspensions of 9 * 107 and 1.8 * 108 cells for the log and stationary 
phase cultures, respectively, were used for RNA extraction. The RNA was run on a denaturing 
gel and blotted to a nylon membrane as described (see Figure 9). Finally, a probe for pcm2 was 
hybridized to the membrane, which was exposed to film and developed. Transcripts for pcm2 
were detected in both the LNP35t log phase (Lane A) and LNP35t stationary phase (Lane B) 
lanes, showing the pNPT/ADE1-3/pcm2 does, indeed, provide a functional source of Pcm2p.  
Previous experiments have shown that endogenous pcm2 transcription is increased in 
stationary phase cells relative to log phase cells (Northern, unpublished data). In this experiment, 
much less total RNA was present in the LNP35t stationary phase lane than in the LNP35t log 
phase lane, as seen on the gel. The Northern blot reflects this same relative level of pcm2 
expression, as there was less pcm2 transcript detected in the stationary phase lane. This suggests 
that unlike the endogenous transcript, plasmid-encoded transcripts are not present at higher 
levels in stationary LNP35t cells than in log LNP35t cells. This further suggests that the 
regulation of the plasmid-encoded pcm2 gene is not identical to that of the native gene, even 
though flanking regions were cloned into the pNPT vector. 
Mutagenesis of LNP35t: 
For a synthetic lethal screen, optimal results are expected when approximately 60% of 
cells are killed by the mutagen. This is achieved by adjusting the length of time of mutagenesis 
and/or the amount of mutagen used. The first step of the mutagenesis was to run several trials to 
determine the correct parameters. I used a constant 20 µL dose of ethylmethanesulfate (EMS) for  
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 Figure 9
Presence of pcm2 transcripts in LNP35t and CLP01 cells. a) denaturing agarose gel of extracted 
RNA, with Standard Markers in first lane; b) Northern blot of gel 
 
Lane A: LNP35t log phase cells, showing pcm2 transcripts from pNPT/ADE1-3/pcm2 
Lane L: 975 log phase cells 
Lane B: LNP35t stationary phase cells, showing pcm2 transcripts from pNPT/ADE1-3/pcm2 
Lane C: CLP01 stationary phase cells, showing pcm2 transcripts from pNMT:pcm2/Leu2. 
Lane S: 975 stationary phase cells 
L SB C Ab.a. B CA L S 
2604 bp 
1383 bp 
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a 1 mL aliquot of approximately 1.33 * 108 cells, and performed rounds of mutagenesis for 
various times. The percent killing was determined by comparing the number of living cells after 
mutagenesis (as determined by counting colonies in plated dilutions) to the initial number of 
cells mutagenized, and adjusting for random killing with a negative control group of cells that 
went through the whole procedure without EMS exposure. After trying timepoints varying from 
30-120 minutes, I determined that 30 minutes was the optimal time to use for approximately 60% 
killing. After this, the percent killing was evaluated following each round of mutagenesis, and 
the amount of EMS used was varied as needed (up to 40-50 µL) each time to obtain 60 % killing. 
Several rounds of mutagenesis were then performed on LNP35t log phase cultures (see 
Figure 10). Mutagenized cells were then plated on YEA solid media and grown at the stress 
temperature of 37˚C for 3-4 days. This temperature was chosen for screening because pcm2 
transcription in S. pombe increases at elevated temperatures, possibly reflecting an increased 
importance of pcm2 at high temperatures. We hypothesize that there is an increased possibility of 
isolating a synthetic lethal mutant at elevated temperatures. 
Screening of Mutagenized Cells: 
This screen takes advantage of properties of the adenine biosynthetic pathway, which 
contains two key genes, ade1 and ade6. When cells grow on media that has little or no adenine, 
both of these genes become active. The ade1 gene product produces a red intermediate that the 
ade6 gene product converts into a colorless product. If both genes are functional, the path will 
run all the way through, and the cells will appear white in color. The cells will also appear white 
if they are ade1-deficient because no red intermediate will ever be made. However, cells that are 
ade1+ ade6- will build up the red intermediate and appear red. LNP35t is ade1+ ade6-, so it 
grows red on YEA plates, which have low amounts of adenine. However, since YEA plates  
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Figure 10 
 
Experiment EMS 
(uL) 
Killing 
(%) 
Total colonies 
screened 
Mutants from 
1˚ screen 
Mutants from 
2˚ screen 
Potential 
synthetic 
lethals 
A 40 29.0 
 
62,300 2 2 KBP4 
KBP5 
B 45 37.6 29,100 1 0  
C 50 95.4 5,760 4 0  
D 45 62.4 24,300 10 2 KBP6 
KBP7 
E 45 67.8 43,500 32 6 KBP8 
 
 
Summary of mutagenesis performed on LNP35t 
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aren’t selective (i.e. don’t contain geneticin), LNP35t can throw out the pNPT/ADE1-3/pcm2 
plasmid, which then makes the cells ade1-ade6- and white in color. As some individual cells in a 
colony throw out the plasmid while others don’t, this causes red and white patches within single 
colonies. Colonies that do this are said to sector. 
The synthetic lethal screen assumes that if the cells need either pcm2 or a compensating 
gene to survive, and the mutagen causes a mutation in the compensating gene, the mutated cells 
will then require the presence of the pNPT/ADE1-3/pcm2 plasmid to encode functional pcm2. If 
the cells can no longer throw out the plasmid because they rely on it for survival, they will not 
sector. Thus, mutagenized cells grown on YEA media were screened for colonies that appeared 
unable to sector. 
Any colony that appeared uniformly red was streaked onto a fresh YEA plate and 
incubated at 37 ˚C for 3-4 days. Two additional rounds of screening were done to ensure that 
non-sectoring colonies were homogeneous. Currently, after screening approximately 1.65 * 105 
colonies, I have identified five such strains, KBP4-8 (see Figure 10). I am in the process of 
performing more rounds of mutagenesis to identify more potential synthetic lethal strains. 
Testing of potential synthetic lethal strains: 
The next step is to do a “plasmid shuffle,” or to transform KBP4-8 with a second plasmid 
(pNMT:pcm2/Leu2) which also contains functional pcm2, and has Leu2 as the selective marker. I 
then select for strains that lose the pNPT/ADE1-3/pcm2 plasmid while retaining the 
pNMT:pcm2/Leu2 plasmid. The purpose of the shuffle is two-fold. First, it ensures that the 
pNPT/ADE1-3/pcm2 plasmid has not integrated itself into the genomic DNA. If it had, the cells 
would be unable to sector and would have been identified falsely as potential synthetic lethals. 
The easiest way to test for this is to look for the plasmid to be thrown out. However, if the strain 
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is actually a synthetic lethal strain, the cells won’t be able to lose the pNPT/ADE1-3/pcm2 
plasmid unless they get another source of pcm2 or the compensating gene. This leads to the 
second reason for the plasmid shuffle: it also ensures that the cells’ inability to sector was 
actually due to a dependence on pcm2 expression, and not on some other mutation. For example, 
a mutation that changes cell membrane permeability might make cells unable to lose plasmids. If 
the cells’ reliance on the pcm2 gene in pNPT/ADE1-3/pcm2 was the only reason why they didn’t 
sector, the pcm2 gene in pNMT:pcm2/Leu2 should be able to sustain them as well. Thus, 
potential synthetic lethal cells transformed with the pNMT:pcm2/Leu2 plasmid should be able to 
sector on PM –leucine plates lacking adenine. 
The pNMT:pcm2/Leu2 plasmid was constructed previously in our lab (Levasseur and 
Heinecke, unpublished data). Since the success of this plasmid shuffle depends on the production 
of pcm2 by this plasmid, my first step was to show that pNMT:pcm2/Leu2 does indeed provide 
pcm2 transcripts. I did this by doing a Northern blot of RNA extracted from a strain that carries 
the plasmid, CLP01 (leu1-32; pNMT:pcm2/Leu2). 
A culture of CLP01 was grown in PM –leucine liquid media at 30 ˚C to a density of  
6.73 * 107 c/mL.  A suspension of 1.8 * 108 cells was used for RNA extraction. The RNA was 
run on a denaturing gel and blotted to a nylon membrane as described. Finally, a probe for pcm2 
was hybridized to the membrane, and autoradiography was used to identify pcm2 transcripts. 
Pcm2p encoding RNA was detected in the CLP01 lane (see Figure 9). Because only the coding 
sequence of pcm2 was cloned into the pNMT vector, the expected transcript size is 
approximately 900 bp, considerably smaller than that expected for the pNPT insert, which 
included much of the pcm2 5’ and 3’ flanking regions, including three potential polyadenylation 
sites. Because the larger insert was used for the pNPT clone, the transcript may be closer to the 
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1.2 kb size of the major endogenous transcript, as determined previously in our lab (Northern, 
unpublished data). The CLP01 band shows large amounts of RNA detected, which makes sense 
because transcription of the pNMT:pcm2/Leu2 DNA is driven by the powerful pnmt41 promoter, 
which causes overexpression with an induction ratio of approximately 25 times (Forsburg 1993). 
This blot also contained two lanes of strain 975 wild-type RNA, one from log phase 
(Lane L) and one from stationary phase (Lane S). The blot exposure was not long enough to 
detect endogenous pcm2 RNA in either lane, while it was long enough to detect products from 
both plasmids in the other lanes. This indicates that the plasmids are very active. While I would 
have liked to see endogenous RNA in the wild-type lanes, the purpose of this experiment was to 
show pcm2 expression from both plasmids, and this blot clearly does this. 
Once I knew that pNMT:pcm2/Leu2 does make Pcm2p, I could begin the plasmid shuffle. 
Potential synthetic lethal strains are being transformed with pNMT:pcm2/Leu2 using the rapid 
transformation method as described. Strains are then screened for their ability to survive with 
only the pNMT:pcm2/Leu2 plasmid. This screening is done by streaking transformed cells (those 
that grow on –leucine plates) onto PM –leucine –adenine plates and looking for streaks that 
sector. I have successfully transformed KBP4 and KBP5 and am in the process of screening 
transformants on PM –leucine –adenine plates. I am also in the process of transforming KBP6-8. 
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Chapter 6: Discussion and Future Work 
One of the goals of my project was to study the effect of Pcm2p expression on stress 
responses and to determine if changes in pcm2 expression occurred when cells were subjected to 
stresses. I tested the knockout strain APP1 under various conditions in search of a phenotypic 
effect associated with loss of pcm2. Long-term stationary phase growth at both 30 ˚C and 36 ˚C 
showed no consistent difference between APP1 and the control FWP10. Growth in high salt, 
high sugar, and high pH conditions at both 30 ˚C and 37 ˚C also showed no difference between 
APP1 and wild-type 975. 
Unfortunately, I was unable to determine if stress treatments led to changes in pcm2 gene 
transcription, as measured with Real-Time PCR. I successfully extracted RNA from S. pombe 
cultures during log phase growth and under six different stress conditions. Gel analysis of the 
samples after Real-Time PCR confirmed that the PCR had worked correctly, but that the results 
had either not been accurately recorded or accurately analyzed. In these experiments, the Real-
Time data and threshold values did not agree with the more qualitative data obtained from the 
gel. Thus, I cannot yet make any conclusions about the relative expression of pcm2 during 
different stress conditions. More work needs to be done with the Real-Time PCR machine and 
analysis software to make the output agree with the visible gel results. Once the Real-Time 
results can be confirmed by gel analysis, the threshold values given for each stress sample can be 
compared, and conclusions drawn about pcm2 expression following stress. Microarray data in 
similar experiments leads us to anticipate that pcm2 transcription will increase during heat shock, 
but not during osmotic shock. 
The failure of Pcm2p to affect phenotypes may be due to the presence of another S. 
pombe protein whose function can compensate for loss of Pcm2p. Loss of PIMT function causes 
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problems in many other organisms; there is no reason to suggest that PIMT is simply 
unimportant in S. pombe. A synthetic lethal screen is a powerful method to identify such genes. I 
have now completed several initial screenings and have isolated five potential mutants. 
Many steps of the synthetic lethal screen have been completed so far; however, there are 
still several additional steps that need to be done. The potential synthetic lethal mutants must be 
further screened to ensure that the mutation causing the inability to sector is actually in a gene 
whose product can compensate for loss of pcm2. In some cases, a mutation in a gene whose 
product influences membrane permeability could cause inability to sector, or a mutation in a 
gene whose product is part of the adenine pathway could make the cell appear red even if it has 
lost the plasmid. There are a number of other mutations that could give a false positive result 
during the initial screen. The next two steps of the synthetic lethal screen, the plasmid shuffle 
and the backcrossing, ensure that we will be left only will strains with legitimate synthetic lethal 
mutations. 
In the plasmid shuffle, each of the potential synthetic lethal mutants will be transformed 
with pNMT:pcm2/Leu2. Each doubly transformed strain must prove itself to be able to sector, by 
losing pNPT/ADE1-3/pcm2, on PM –leucine –adenine media. A double mutant that successfully 
does this would appear initially red and then become white as it lost pNPT/ADE1-3/pcm2. As 
described earlier, this ensures that pNPT/ADE1-3/pcm2 has not integrated into the genomic 
DNA, and ensures that the yeast has been unable to sector because of its reliance on the 
pNPT/ADE1-3/pcm2’s functional pcm2. 
Any mutants that successfully complete the plasmid shuffle will then take part in a series 
of backcrosses. Since the mutagenesis likely resulted in more than one mutation per cell, each 
original potential synthetic lethal strain (such as KBP4; not the double-transformed mutant) must 
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be backcrossed three times with LNP35t, each time selecting for cells that are unable to sector. 
This will give final strains that are identical to LNP35t except for the mutation in the 
compensating gene. Three backcrosses is enough to statistically ensure that any additional 
mutations, those not pertaining to Pcm2p function, will be crossed out. 
These backcrossed strains can then be used to identify the compensating gene. Genetic 
complementation using an S. pombe cDNA library will be utilized. The final backcrossed strains 
will be transformed with plasmids containing various genes from the library. Like in the plasmid 
shuffle, if cells are able to sector (i.e. lose pNPT/ADE1-3/pcm2) once they acquire a second 
plasmid, this means that the second plasmid must contain either pcm2 or a compensating gene. 
Thus, any cell that is able to sector with the presence of the new plasmid will be selected. The 
library plasmid from these cells can be isolated and its inserted gene will be identified by DNA 
sequencing. 
The five potential mutants isolated in this project were obtained by screening 1.65 * 105 
colonies. I expect that several of these will be eliminated in subsequent steps. Although the 
number of synthetic interactors is low, this is not without precedent. A recent genome-wide 
screen for synthetic interactors in budding yeast revealed that this number could vary from 0 to 
146 (Tong et al 2004). The isolation and identification of this gene from one of these five 
mutants would confirm the importance of PIMT in S. pombe by indicating the presence of a 
redundant mechanism to prevent loss of essential PIMT function. 
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